In breast cancer, RAB31 was first identified as an independent prognostic factor, and was subsequently found to interact with the mucin 1 C-terminal subunit oncoprotein to promote cancer progression and subsequent tamoxifen resistance in patients (13–16). The gene discussed is RAB31; the disease is cancer.